New changes to the Alzheimer's diagnosis to include a spectrum of three phases: outright Alzheimer's, mild cognitive (brain) impairment, and the new phase of sub-clinical Alzheimer's (no cognitive symptoms) .
Tests still in clinical trial phase include brain scans and cerebrospinal fluid tests which may identify lab markers corresponding with future development of outright Alzheimer's (New York Times article here).
Since there is no anti-Alzheimer's drug (yet?), early identification does not give much hope to our conventional medical counterparts. But with all the natural approaches Naturopathic Doctors offer to optimize brain function and nervous system health, get in touch with one if you have any cognitive performance concerns for yourself or family members. If you need help in finding your local Naturopath, look here!
Thanks for reading. Support from my readers is much appreciated!
-Angela
Tests still in clinical trial phase include brain scans and cerebrospinal fluid tests which may identify lab markers corresponding with future development of outright Alzheimer's (New York Times article here).
Since there is no anti-Alzheimer's drug (yet?), early identification does not give much hope to our conventional medical counterparts. But with all the natural approaches Naturopathic Doctors offer to optimize brain function and nervous system health, get in touch with one if you have any cognitive performance concerns for yourself or family members. If you need help in finding your local Naturopath, look here!
Thanks for reading. Support from my readers is much appreciated!
-Angela
